CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case studyTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGYIF4.22023-11-101OAAI
Reflections of mentors and mentees on a national mentoring programme for pharmacists in the United Kingdom: An examination into organisational culture and systemsRESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACYIF2.82022-04-013OAAI
Reflections of mentors and mentees on a national mentoring programme for pharmacists: An examination into relationships, personal and professional developmentRESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACYIF2.82022-03-0111OAAI
Representation of Racial and Ethnic Minority Populations in Dementia Prevention Trials: A Systematic ReviewJPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASEIF7.82022-01-0129OA
Design fundamentals of mentoring programs for pharmacy professionals (Part 2): Considerations for mentors and menteesRESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACYIF2.82021-02-019OAAI
Design fundamentals of mentoring programs for pharmacy professionals (Part 1): Considerations for organizationsRESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACYIF2.82021-02-0116OAAI